Back to 
RA Capital Management, L.P.
RA Capital Management, L.P.
AXSM
Showing 3 of 19 quarters
Position history for RA Capital Management, L.P.'s holdings in Axsome Therapeutics, Inc.
No. RA Capital Management exited its AXSM (Axsome Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 1,000,000 shares worth $84.6M. RA Capital Management first reported AXSM in Q1 2019 and held it in 17 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$89.9M
Total Shares Change
-1M
Quarter-by-Quarter History